VGP’s ballast water monitoring requirements apply to ballast water discharges from vessels employing ballast water treatment systems that are used to achieve the effluent limitations.
Once a ballast water treatment system is required to be installed onboard a vessel, any ballast water discharges from such vessels will be subject to the effluent limitations of this permit. To ascertain compliance with the effluent limitation in that section, EPA is establishing the following biological indicator compliance monitoring.
Type of Monitoring | Devices for Which High Quality Type Approval Data Are Available | Devices for Which High Quality Data Are Not Available |
---|---|---|
Intial | 2 times | 4 times per year |
Maintenance | 1 or 2 times per year (*) | 4 times per year |
(*)if sampling results are below permit limits for two consecutive events, the vessel owner/operator may reduce monitoring to one time per year after the first year.
Biological indicator compliance monitoring sampling of ballast water effluent must be conducted 2 times during the first year the system is installed or used for vessels with Devices for Which High Quality Type Approval Data Are Available are available.
For vessels with high quality data, if sampling results are below permit limits for two consecutive events, the vessel owner/operator may reduce monitoring to one time per year after the first year.
However, if the vessel owner/operator exceeds a permit limit on any sampling event, they must return to monitoring two times per year until they have two additional results below permit limits.
For vessels for which high quality data are not available, monitoring must be conducted 4 times per year.
For all vessels, one of those samples may be conducted as part a vessel’s annual or other survey, and during the first year, one of those sampling events may be conducted as part of the installation of the system to ensure it is functioning properly.
These samples can be taken by collecting a small volume sample from the ballast water discharge (consistent with the sampling guidance found in EPA’s Generic Protocol for the Verification of Ballast Water Treatment Technology – ETV Protocol).
Many ballast water treatment systems produce or use biocides as an agent to reduce living organisms present in the ballast water tank.
For those vessels, Operator must conduct monitoring of the vessel ballast water discharge for any residual biocides or derivatives used in the treatment process, in part to demonstrate compliance with the permits conditions.
In order to demonstrate that residual biocides or derivatives are in compliance with this permit, that substantial quantities of harmful byproducts are not produced, and provide EPA with needed information about system functionality, the vessel operator initially must take samples according to the following:
Type of Monitoring | Devices for Which High Quality Type Approval Data Are Available | Devices for Which High Quality Type Approval Data Are Not Available |
---|---|---|
Intial | 3 times in the first 10 discharge events (not to exceed a 180 day period). | 5 times in the first 10 discharge events (not to exceed a 180 day period). |
Maintenance | 2 times per year | 4 times per year |
Each system, depending on the disinfection method it uses has different monitoring requirements, the table below shows those requirements per Biocide category.
Biocide | Analyte | Analytical Methods | Minimum Sample Volume | Sample Holding Time | MDL | Effluent Limit or Action | Limit Type |
---|---|---|---|---|---|---|---|
Alkylamines | Alkylamines | EPA Method 8360B and 8270D | 25 mL (8260B) | 14 days (8260B) | Varies by compound (8260D); 10 μg/L (8270C) | Report | NA |
Chlorine or Chlorine Dioxide* | Chlorine Dioxide* | EPA Method 327.0-1; SM 4500 ClO2 E | 16 mL (327.0-1) | 4 hours (327.0-1); As soon as possible(SM) | Varies (327.0-1); 10 to 100 mg/L (SM) | 200 μg/L | Instantaneous Maximum |
Total Residual Oxidizers (TRO) as Cl2* | SM 4500-Cl G; ISO 7393/2 | 50 mL | 15 minutes | 10 μg/L, under ideal conditions | 100 μg/L | Instantaneous Maximum | |
Chlorite | EPA Method 300.1 | CFU or 250 mL |
14 days | Varies | Report | NA | |
Chlorate | EPA Method 300.1 | 250 mL | 28 days | Varies | Report | NA | |
Total trihalomethanes** | EPA Method 8260 | 25 mL | 14 days | Varies | Report | NA | |
Haloacetic acids*** | EPA Method 552.2 | 40 mL | 14 days | Varies by compound | Report | NA | |
Menadione | Menadione | NA | -- | -- | -- | Report | NA |
Ozone | Total Residual Oxidizers (TRO) as Cl2 | SM 4500-Cl G; ISO 7393/2 | 50 mL | 15 minutes | 10 μg/L, under ideal conditions | 100 μg/L | Instantaneous Maximum |
Bromate | EPA Method 317 ; EPA Method 300.1; ASTM D 6581-00 | 250 mL | 28 days (317; 300.1) | Varies (317; 300.1) | Report | NA | |
Bromoform | EPA Method 8260 | 25 mL | 14 days | Varies | Report | NA | |
Total trihalomethanes** | EPA Method 8260 | 25 mL | 14 days | Varies | Report | NA | |
Haloacetic acids*** | EPA Method 552.2 | 40 mL | 14 days | Varies by compound | Report | NA | |
Peracetic acid | pH | SM 4500 H+ | 25 mL | As soon as possible | NA | 6.5 – 9 s.u | Instantaneous Maximum |
Peracetic acid | Photometric analysis(Pinkernell, 1997; EMD Chemicals, 2011; CHEMetrics 2010) | 25 mL | As soon as possible | 500 μg/L | Report | NA | |
Hydrogen peroxide | Titimetric analysis (JIS K 1463:2007; EMD Chemicals, 2011; CHEMetrics 2010)) | 25 mL | As soon as possible | 500 μg/L | 1000 μg/L | NA |
* Chorine Dioxide Systems do need to monitor TRO, Chlorine Systems do need to monitor Chlorine Dioxide Content
**Total trihalomethanes is the sum of the concentrations of chloroform, bromodichloromethane, dibromochloromethane, and bromoform.
***Haloacetic acids is the sum of the concentrations of mono-, di-, and trichloroacetic acids and mono- and dibromoacetic acids.
Tribocare Brochure VGP Monitoring Requirements
Need help or have a question?
UNITED ARAB EMIRATES
Tribocare FZC
A2-74 SAIF Zone
Sharjah, UAE
T: +971 65528799
E: sharjah@tribocare.com
SINGAPORE
Tribocare PTE LTD
32, Pandan Road,
Singapore 609279
T: + 65 62642840
E: singapore@tribocare.com
CHINA
Tribocare Shanghai CO., LTD.
Room 202 Block 32, No.3999
Xiupu Road, Pudong District,
Shanghai, China
地址:上海市浦东新区秀浦路3999弄, 32号二层202室
T: +86 18621601008
E: china@tribocare.com
GERMANY
Tribocare GMBH
E: germany@tribocare.com
GREECE
Pentelis 53
Marousi 15126
Greece
T: +30 213 031 9384
Mob: +30 694 649 0604
E: greece@tribocare.com
NETHERLANDS
Tribocare B.V.
Delta-Industrieweg 14
Stellendam,
Netherlands
3251 LX
E: netherlands@tribocare.com
USA
Tribocare INC
E: americas@tribocare.com
Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur. " Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur.